McLean WH - Search Results

1

Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex.

Atkinson SD, McGilligan VE, Liao H, Szeverenyi I, Smith FJ, Moore CB, McLean WH. Atkinson SD, et al. Among authors: mclean wh. J Invest Dermatol. 2011 Oct;131(10):2079-86. doi: 10.1038/jid.2011.169. Epub 2011 Jun 30. J Invest Dermatol. 2011. PMID: 21716320 Free article.

2

A novel connexin 30 mutation in Clouston syndrome.

Smith FJ, Morley SM, McLean WH. Smith FJ, et al. Among authors: mclean wh. J Invest Dermatol. 2002 Mar;118(3):530-2. doi: 10.1046/j.0022-202x.2001.01689.x. J Invest Dermatol. 2002. PMID: 11874494 Free article.

3

Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex.

Smith FJ, Morley SM, McLean WH. Smith FJ, et al. Among authors: mclean wh. J Invest Dermatol. 2004 Jan;122(1):73-7. doi: 10.1046/j.0022-202X.2003.22129.x. J Invest Dermatol. 2004. PMID: 14962092 Free article.

4

Insights into genotype-phenotype correlation in pachyonychia congenita from the human intermediate filament mutation database.

McLean WH, Smith FJ, Cassidy AJ. McLean WH, et al. J Investig Dermatol Symp Proc. 2005 Oct;10(1):31-6. doi: 10.1111/j.1087-0024.2005.10205.x. J Investig Dermatol Symp Proc. 2005. PMID: 16250207 Free article. Review.

5

Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis.

Liao H, Waters AJ, Goudie DR, Aitken DA, Graham G, Smith FJ, Lewis-Jones S, McLean WH. Liao H, et al. Among authors: mclean wh. J Invest Dermatol. 2007 Dec;127(12):2795-8. doi: 10.1038/sj.jid.5700971. Epub 2007 Jul 26. J Invest Dermatol. 2007. PMID: 17657246 Free article.

6

Development of therapeutic siRNAs for pachyonychia congenita.

Smith FJ, Hickerson RP, Sayers JM, Reeves RE, Contag CH, Leake D, Kaspar RL, McLean WH. Smith FJ, et al. Among authors: mclean wh. J Invest Dermatol. 2008 Jan;128(1):50-8. doi: 10.1038/sj.jid.5701040. Epub 2007 Aug 30. J Invest Dermatol. 2008. PMID: 17762855 Free article.

7

Keratin K6c mutations cause focal palmoplantar keratoderma.

Wilson NJ, Messenger AG, Leachman SA, O'Toole EA, Lane EB, McLean WH, Smith FJ. Wilson NJ, et al. Among authors: mclean wh. J Invest Dermatol. 2010 Feb;130(2):425-9. doi: 10.1038/jid.2009.215. Epub 2009 Jul 16. J Invest Dermatol. 2010. PMID: 19609311 Free article.

8

Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita.

Zhao Y, Gartner U, Smith FJ, McLean WH. Zhao Y, et al. Among authors: mclean wh. J Invest Dermatol. 2011 May;131(5):1045-52. doi: 10.1038/jid.2011.41. Epub 2011 Mar 10. J Invest Dermatol. 2011. PMID: 21390048 Free article.

9

The phenotypic and molecular genetic features of pachyonychia congenita.

McLean WH, Hansen CD, Eliason MJ, Smith FJ. McLean WH, et al. J Invest Dermatol. 2011 May;131(5):1015-7. doi: 10.1038/jid.2011.59. Epub 2011 Mar 24. J Invest Dermatol. 2011. PMID: 21430705 Free article. Review.

10

Keratin disorders: from gene to therapy.

McLean WH, Moore CB. McLean WH, et al. Hum Mol Genet. 2011 Oct 15;20(R2):R189-97. doi: 10.1093/hmg/ddr379. Epub 2011 Sep 2. Hum Mol Genet. 2011. PMID: 21890491 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page